Strata Critical Medical grants Wunsch stock awards

Q: How many shares did SRTA withhold for taxes?

Strata Critical Medical withheld 44,996 shares at $4.76 per share on October 28, 2026, to satisfy tax withholding obligations connected with vesting of performance-based restricted stock units.

The RSU awards have vesting dates from September 8, 2026, through March 8, 2027, with continued-service conditions.

Available on EDGAR 10/30/2026 - 04:06 PM EDT Accepted by SEC EDGAR 10/30/2026 - 04:06 PM EDT

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Strata Critical Medical, Inc. reports equity awards to Scott M. Wunsch, CEO, Logistics, and shares withheld for taxes. On October 28, 2026, two award entries each list 57,173 shares acquired upon certification of performance criteria; a separate 1,416-share RSU grant vests March 8, 2027, subject to continued service. RSU grants of 9,787 and 2,658 shares on July 30 vest September 8 and December 8, 2026, respectively, subject to continued service. The issuer withheld 44,996 shares at $4.76 per share for tax obligations. An LLC of which Wunsch is sole member held 382,987 shares on July 30, 2026.

Insider Trade Summary

6 transactions reported

Mixed 6 txns

Insider Wunsch Scott M

Role CEO, Logistics

Type	Security	Shares	Price	Value
Grant/Award	Class A common stock, $0.0001 par value per share ^F3	57,173	$0.00	$0.00
Grant/Award	Class A common stock, $0.0001 par value per share ^F3	57,173	$0.00	$0.00
Grant/Award	Class A common stock, $0.0001 par value per share ^F4	1,416	$0.00	$0.00
Tax Withholding	Class A common stock, $0.0001 par value per share ^F5	44,996	$4.76	$214K
Grant/Award	Class A common stock, $0.0001 par value per share ^F1	9,787	$0.00	$0.00
Grant/Award	Class A common stock, $0.0001 par value per share ^F2	2,658	$0.00	$0.00
Holding	Class A common stock, $0.0001 par value per share ^F6	--	--	--

Holdings After Transaction: Class A common stock, $0.0001 par value per share — 746,254 shares (Direct); Class A common stock, $0.0001 par value per share — 382,987 shares (Indirect, See Footnotes)

Holdings Before and After: Class A common stock, $0.0001 par value per share, 663,043 to 746,254 shares (Direct)

Footnotes (6)

F1. Represents a grant of Restricted Stock Units ("RSUs") which will be settled in shares of the Issuer's common stock upon vesting. 100% of the RSUs will vest on September 8, 2026, subject to the Reporting Person's continued service to the Issuer. The RSUs represent an award under the Reporting Person's quarterly commission program.
F2. Represents a grant of RSUs which will be settled in shares of the Issuer's common stock upon vesting. 100% of the RSUs will vest on December 8, 2026, subject to the Reporting Person's continued service to the Issuer. The RSUs represent an award under the Reporting Person's quarterly commission program.
F3. Represents shares that were acquired upon the certification of the Compensation Committee of the Issuer's Board of Directors of the satisfaction of performance criteria underlying an award of performance-based restricted stock units ("PSUs") granted to the Reporting Person on March 20, 2025.
F4. Represents a grant of RSUs which will be settled in shares of the Issuer's common stock upon vesting. 100% of the RSUs will vest on March 8, 2027, subject to the Reporting Person's continued service to the Issuer. The RSUs represent an award under the Reporting Person's quarterly commission program.
F5. Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of PSUs.
F6. Held directly by a limited liability company of which the Reporting Person is the sole member.

Key Figures

Performance-award shares: 57,173 shares per reported entry RSU grant: 9,787 shares RSU grant: 2,658 shares +4 more

7 metrics

Performance-award shares 57,173 shares per reported entry Two award entries dated October 28, 2026; acquired upon certification of performance criteria

RSU grant 9,787 shares Granted July 30, 2026; scheduled to vest September 8, 2026, subject to continued service

RSU grant 2,658 shares Granted July 30, 2026; scheduled to vest December 8, 2026, subject to continued service

RSU grant 1,416 shares October 28, 2026; scheduled to vest March 8, 2027, subject to continued service

Shares withheld for tax obligations 44,996 shares October 28, 2026, in connection with vesting of PSUs

Withholding price $4.76 per share October 28, 2026

Shares held by LLC 382,987 shares Held by an LLC of which Scott M. Wunsch is sole member, as of July 30, 2026

Key Terms

Restricted Stock Units (RSUs), performance-based restricted stock units (PSUs), quarterly commission program, tax withholding obligations

4 terms

Restricted Stock Units (RSUs) financial

"grant of RSUs which will be settled in shares"

Restricted stock units (RSUs) are a type of company promise to give employees shares of stock in the future, usually after certain conditions like working for a set time. They are like a gift promised today that you receive later, which can become valuable if the company's stock price goes up. RSUs matter because they are a way companies reward employees and can be a significant part of compensation.

performance-based restricted stock units (PSUs) financial

"award of performance-based restricted stock units"

quarterly commission program financial

"award under the Reporting Person's quarterly commission program"

tax withholding obligations financial

"satisfy tax withholding obligations in connection with the vesting of PSUs"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many shares did SRTA's Scott M. Wunsch acquire through awards?

On October 28, 2026, two award entries each list 57,173 shares acquired upon certification of performance criteria, plus a separate 1,416-share RSU grant. On July 30, 2026, he also received RSU grants of 9,787 and 2,658 shares.

How many shares did SRTA withhold for taxes?

Strata Critical Medical withheld 44,996 shares at $4.76 per share on October 28, 2026, to satisfy tax withholding obligations connected with vesting of performance-based restricted stock units.

When do Scott M. Wunsch's SRTA RSU awards vest?

The 9,787-share RSU grant vests September 8, 2026, and the 2,658-share grant vests December 8, 2026; both are subject to continued service. The 1,416-share grant vests March 8, 2027, also subject to continued service. The RSU grants are awards under the quarterly commission program.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Wunsch Scott M

(Last)

(First)

(Middle)

C/O STRATA CRITICAL MEDICAL, INC.

666 THIRD AVENUE, 25TH FLOOR

(Street)

NEW YORK

10017

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Strata Critical Medical, Inc. [ SRTA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	CEO, Logistics

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/30/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Class A common stock, $0.0001 par value per share	07/30/2026		A		9,787⁽¹⁾	A	$0	672,830	D
Class A common stock, $0.0001 par value per share	07/30/2026		A		2,658⁽²⁾	A	$0	675,488	D
Class A common stock, $0.0001 par value per share	10/28/2026		A		57,173⁽³⁾	A	$0	732,661	D
Class A common stock, $0.0001 par value per share	10/28/2026		A		57,173⁽³⁾	A	$0	789,834	D
Class A common stock, $0.0001 par value per share	10/28/2026		A		1,416⁽⁴⁾	A	$0	791,250	D
Class A common stock, $0.0001 par value per share	10/28/2026		F		44,996⁽⁵⁾	D	$4.76	746,254	D
Class A common stock, $0.0001 par value per share								382,987	I⁽⁶⁾	See Footnotes

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Represents a grant of Restricted Stock Units ("RSUs") which will be settled in shares of the Issuer's common stock upon vesting. 100% of the RSUs will vest on September 8, 2026, subject to the Reporting Person's continued service to the Issuer. The RSUs represent an award under the Reporting Person's quarterly commission program.

2. Represents a grant of RSUs which will be settled in shares of the Issuer's common stock upon vesting. 100% of the RSUs will vest on December 8, 2026, subject to the Reporting Person's continued service to the Issuer. The RSUs represent an award under the Reporting Person's quarterly commission program.

3. Represents shares that were acquired upon the certification of the Compensation Committee of the Issuer's Board of Directors of the satisfaction of performance criteria underlying an award of performance-based restricted stock units ("PSUs") granted to the Reporting Person on March 20, 2025.

4. Represents a grant of RSUs which will be settled in shares of the Issuer's common stock upon vesting. 100% of the RSUs will vest on March 8, 2027, subject to the Reporting Person's continued service to the Issuer. The RSUs represent an award under the Reporting Person's quarterly commission program.

5. Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of PSUs.

6. Held directly by a limited liability company of which the Reporting Person is the sole member.

Remarks:

	/s/ Melissa M. Tomkiel, Attorney-in-fact for Scott M. Wunsch	10/30/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR